Derma Sciences, Inc. (OTC BB: DSCI)

Derma Sciences, Inc. (OTC BB: DSCI), a global manufacturer and marketer of advanced wound-care products, sells its primary product, MEDIHONEY(TM), around the globe through Derma Sciences and Comvita New Zealand, and is known as the leading brand of honey-based dressings for wounds and burns. MEDIHONEY has been proven to effectively treat a variety of wounds and burns, and was recently the focus of a large-scale randomized controlled trial on leg ulcers. For further information, visit the Company’s web site at www.dermasciences.com.